Image

2:39 AM / Wednesday October 5, 2022

2 Jul 2021

J&J agrees to pay $230M to settle New York opioid claim

  • Facebook
  • Twitter
July 2, 2021 Category: Week In Review Posted by:

ABOVE PHOTO: New York Attorney General Letitia James addresses a news conference at her office, in New York, Friday, May 21, 2021. James said Friday that an ongoing investigation surrounding Gov. Andrew Cuomo will “conclude when it concludes,” and said she has ignored criticism from his top aide that the probe is politically motivated. (AP Photo/Richard Drew)

ASSOCIATED PRESS 

NEW YORK  — Johnson & Johnson has agreed to pay $230 million to New York state to settle claims that the pharmaceutical giant helped fuel the opioid crisis, Attorney General Letitia James said on Saturday.

The drug maker also agreed to permanently end the manufacturing and distribution of opioids across New York and the rest of the nation, James said in a statement announcing the settlement.

The company “helped fuel this fire, but today they’re committing to leaving the opioid business — not only in New York, but across the entire country,” she said.

The deal involving a lawsuit brought by James in 2019 removes Johnson & Johnson from a trial that is slated to begin next week on Long Island — part of a slew of litigation over an epidemic linked to nearly 500,000 deaths over the last two decades.

In its own statement on Saturday, Johnson & Johnson downplayed the attorney general’s announcement. It said the settlement involved two prescription painkillers — developed by a subsidiary and accounting for less than 1% of the market — that are already no longer sold in the U.S.

The settlement was “not an admission of liability or wrongdoing by the company,” Johnson & Johnson said. It added that its actions “relating to the marketing and promotion of important prescription pain medications were appropriate and responsible.”

The settlement was the latest development in the complicated universe of opioid-related lawsuits across the U.S. that has drawn comparisons to the multistate litigation against tobacco companies in the 1990s. It reflects a path being taken by some big drug companies that see settling as in their best interests, in part because that route would likely not cost as much as losing in court repeatedly.

Johnson & Johnson — along with distributors AmerisourceBergen, Cardinal Health and McKesson — made public last year that they were offering a total of $26 billion over 18 years to settle all the cases they face, with the money going to abate the crisis.

  • Facebook
  • Twitter

Leave a Comment

Recent News

Stateside

Biden signs bill to avert government shutdown, aid Ukraine

October 1, 2022

Tweet Share Pin Email By KEVIN FREKING WASHINGTON (AP) — President Joe Biden signed into law Friday...

Education

A message from Superintendent Watlington regarding the shooting outside of Roxborough High School

September 30, 2022

Tweet Share Pin Email Dear School District of Philadelphia staff and families, The School District of Philadelphia...

Entertainment

The Jacksons in concert on September 10

September 30, 2022

Tweet Share Pin Email (Photos/Afea Tucker) The Jacksons — Jackie, Tito, and Marlon, along with a backup...

Diaspora

Puerto Ricans await aid, fret about post-hurricane recovery

September 30, 2022

Tweet Share Pin Email ABOVE PHOTO: A man points to a home that was collapsed by Hurricane...

Go With The-Flo

Lil Wayne is looking to make a big profit from the sale of his waterfront Miami Beach mansion

September 30, 2022

Tweet Share Pin Email ABOVE PHOTO: Lil Wayne (Paul Smith / Featureflash / Shutterstock) By Flo Anthony...

Food And Beverage

What’s Cookin’? Vegan Shortbread Cookies

September 30, 2022

Tweet Share Pin Email Tweet Share Pin Email Related Posts What’s Cookin’? Chewy Five Ginger Spice Molasses...

The Philadelphia Sunday Sun Staff